Overbaugh Jason G.

SEC source: 0001096906-24-001949 · primary_doc.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,289

Underlying: Class A Common Stock · 30,289 shares

Expires 2026-12-02

F3 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 08, 2022, July 14, 2023 and July 12, 2024.

SEC source: 0001096906-24-002045 · form4.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 30,289 shares

Expires 2026-12-02

F2 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.

SEC source: 0001096906-16-002098 · primary_doc.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP and Nat'l Marketing Dir. LI

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Class A Common Stock · 21,000 shares

Expires 2025-12-04

F4 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 5, 2016. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 4, 2016, until such shares are fully vested.

F4 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 5, 2016. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 4, 2016, until such shares are fully vested.

F4 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 5, 2016. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 4, 2016, until such shares are fully vested.

F4 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 5, 2016. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 4, 2016, until such shares are fully vested.

F4 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 5, 2016. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 4, 2016, until such shares are fully vested.

SEC source: 0001096906-17-000275 · primary_doc.xml · derivative · entry 6

Overbaugh Jason G. · CIK 0001588310 · Director · VP; Nat. Mrkt. Dir Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,050

Underlying: Class A Common Stock · 22,050 shares

Expires 2025-12-04

F6 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016 and February 3, 2017.

F6 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016 and February 3, 2017.

F6 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016 and February 3, 2017.

F6 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016 and February 3, 2017.

F6 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016 and February 3, 2017.

SEC source: 0001096906-17-000789 · primary_doc.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP and Nat'l Marketing Dir. LI

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,050

Underlying: Class A Common Stock · 22,050 shares

Expires 2025-12-04

F4 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016 and February 3, 2017.

F4 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016 and February 3, 2017.

F4 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016 and February 3, 2017.

F4 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016 and February 3, 2017.

F4 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016 and February 3, 2017.

SEC source: 0001096906-18-000375 · primary_doc.xml · derivative · entry 6

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,153

Underlying: Class A Common Stock · 23,153 shares

Expires 2025-12-04

F6 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, and February 2, 2018.

F6 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, and February 2, 2018.

F6 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, and February 2, 2018.

F6 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, and February 2, 2018.

F6 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, and February 2, 2018.

SEC source: 0001096906-18-000701 · primary_doc.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,153

Underlying: Class A Common Stock · 23,153 shares

Expires 2025-12-04

F4 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, and February 2, 2018.

F4 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, and February 2, 2018.

F4 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, and February 2, 2018.

F4 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, and February 2, 2018.

F4 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, and February 2, 2018.

SEC source: 0001096906-19-000079 · primary_doc.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,311

Underlying: Class A Common Stock · 24,311 shares

Expires 2025-12-04

F6 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F6 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F6 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F6 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F6 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001096906-19-000433 · primary_doc.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,311

Underlying: Class A Common Stock · 24,311 shares

Expires 2025-12-04

F4 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F4 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F4 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F4 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F4 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001096906-20-000010 · primary_doc.xml · derivative · entry 9

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,311

Underlying: Class A Common Stock · 24,311 shares

Expires 2025-12-04

F4 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F4 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F4 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F4 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F4 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001445866-20-000844 · primary_doc.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,527

Underlying: Class A Common Stock · 25,527 shares

Expires 2025-12-04

F4 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

F4 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

F4 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

F4 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

F4 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

SEC source: 0001445866-20-001119 · primary_doc.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,165

Underlying: Class A Common Stock · 26,165 shares

Expires 2025-12-04

F4 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F4 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F4 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F4 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F4 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

SEC source: 0001096906-21-000039 · form4.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Mkting Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,165

Underlying: Class A Common Stock · 26,165 shares

Expires 2025-12-04

F3 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F3 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F3 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F3 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F3 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

SEC source: 0001096906-21-002161 · primary_doc.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,165

Underlying: Class A Common Stock · 26,165 shares

Expires 2025-12-04

F2 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F2 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F2 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F2 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F2 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001096906-21-002160 · primary_doc.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,165

Underlying: Class A Common Stock · 26,165 shares

Expires 2025-12-04

F4 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001493152-21-026009 · ownership.xml · derivative · entry 1

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Class A Common Stock · Not disclosed shares

Expires 2025-12-04

F1 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F1 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F1 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F1 · underlyingValue: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F1 · valueOwnedAfter: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001493152-22-003299 · ownership.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat'l Marketing Dir/Life

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,165

Underlying: Class A Common Stock · 26,165 shares

Expires 2025-12-04

F2 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F2 · shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F2 · price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F2 · derivative.underlying_shares: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F2 · balance_after: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001096906-23-001422 · form4.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,289

Underlying: Class A Common Stock · 30,289 shares

Expires 2025-12-04

F1 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 08, 2022, and July 14, 2023.

SEC source: 0001096906-23-002418 · form4.xml · derivative · entry 1

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,289

Underlying: Class A Common Stock · 30,289 shares

Expires 2025-12-04

F1 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 08, 2022, and July 14, 2023.

SEC source: 0001096906-24-001949 · primary_doc.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 31,803 shares

Expires 2025-12-04

F2 · derivative.exercise_price: This option was granted on December 4, 2015 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 08, 2022, July 14, 2023 and July 12, 2024.

SEC source: 0001096906-16-002098 · primary_doc.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP and Nat'l Marketing Dir. LI

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,050

Underlying: Class A Common Stock · 22,050 shares

Expires 2024-12-05

F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015 and February 5, 2016.

F3 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015 and February 5, 2016.

F3 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015 and February 5, 2016.

F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015 and February 5, 2016.

F3 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015 and February 5, 2016.

SEC source: 0001096906-17-000275 · primary_doc.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP; Nat. Mrkt. Dir Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,153

Underlying: Class A Common Stock · 23,153 shares

Expires 2024-12-05

F5 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F5 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F5 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F5 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F5 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

SEC source: 0001096906-17-000789 · primary_doc.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP and Nat'l Marketing Dir. LI

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,153

Underlying: Class A Common Stock · 23,153 shares

Expires 2024-12-05

F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F3 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F3 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F3 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

SEC source: 0001096906-18-000375 · primary_doc.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,311

Underlying: Class A Common Stock · 24,311 shares

Expires 2024-12-05

F5 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F5 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F5 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F5 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F5 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

SEC source: 0001096906-18-000701 · primary_doc.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,311

Underlying: Class A Common Stock · 24,311 shares

Expires 2024-12-05

F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F3 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F3 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F3 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

SEC source: 0001096906-19-000079 · primary_doc.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,527

Underlying: Class A Common Stock · 25,527 shares

Expires 2024-12-05

F5 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F5 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F5 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F5 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F5 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001096906-19-000433 · primary_doc.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,527

Underlying: Class A Common Stock · 25,527 shares

Expires 2024-12-05

F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F3 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F3 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F3 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001096906-20-000010 · primary_doc.xml · derivative · entry 8

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,527

Underlying: Class A Common Stock · 25,527 shares

Expires 2024-12-05

F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F3 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F3 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F3 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001445866-20-000844 · primary_doc.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,803

Underlying: Class A Common Stock · 26,803 shares

Expires 2024-12-05

F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

F3 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

F3 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

F3 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

SEC source: 0001445866-20-001119 · primary_doc.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,473

Underlying: Class A Common Stock · 27,473 shares

Expires 2024-12-05

F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F3 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F3 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F3 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

SEC source: 0001096906-21-000039 · form4.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Mkting Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,473

Underlying: Class A Common Stock · 27,473 shares

Expires 2024-12-05

F2 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F2 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F2 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F2 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F2 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

SEC source: 0001096906-21-002160 · primary_doc.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 27,473 shares

Expires 2024-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001096906-16-002098 · primary_doc.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP and Nat'l Marketing Dir. LI

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,025

Underlying: Class A Common Stock · 11,025 shares

Expires 2024-07-02

F2 · derivative.exercise_price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015 and February 5, 2016.

F2 · shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015 and February 5, 2016.

F2 · price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015 and February 5, 2016.

F2 · derivative.underlying_shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015 and February 5, 2016.

F2 · balance_after: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015 and February 5, 2016.

SEC source: 0001096906-17-000275 · primary_doc.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP; Nat. Mrkt. Dir Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,576

Underlying: Class A Common Stock · 11,576 shares

Expires 2024-07-02

F4 · derivative.exercise_price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F4 · shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F4 · price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F4 · derivative.underlying_shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F4 · balance_after: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

SEC source: 0001096906-17-000789 · primary_doc.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP and Nat'l Marketing Dir. LI

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,576

Underlying: Class A Common Stock · 11,576 shares

Expires 2024-07-02

F2 · derivative.exercise_price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F2 · shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F2 · price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F2 · derivative.underlying_shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

F2 · balance_after: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016 and February 3, 2017.

SEC source: 0001096906-18-000375 · primary_doc.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,155

Underlying: Class A Common Stock · 12,155 shares

Expires 2024-07-02

F4 · derivative.exercise_price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F4 · shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F4 · price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F4 · derivative.underlying_shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F4 · balance_after: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

SEC source: 0001096906-18-000701 · primary_doc.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,155

Underlying: Class A Common Stock · 12,155 shares

Expires 2024-07-02

F2 · derivative.exercise_price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F2 · shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F2 · price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F2 · derivative.underlying_shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F2 · balance_after: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

SEC source: 0001096906-19-000079 · primary_doc.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,763

Underlying: Class A Common Stock · 12,763 shares

Expires 2024-07-02

F4 · derivative.exercise_price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F4 · shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F4 · price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F4 · derivative.underlying_shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F4 · balance_after: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001096906-19-000433 · primary_doc.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,763

Underlying: Class A Common Stock · 12,763 shares

Expires 2024-07-02

F2 · derivative.exercise_price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F2 · shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F2 · price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F2 · derivative.underlying_shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F2 · balance_after: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001096906-20-000010 · primary_doc.xml · derivative · entry 7

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 12,763 shares

Expires 2024-07-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F2 · shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F2 · price: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F2 · derivative.underlying_shares: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F2 · balance_after: This option was granted on July 2, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.29 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001096906-16-002098 · primary_doc.xml · derivative · entry 1

Overbaugh Jason G. · CIK 0001588310 · Director · VP and Nat'l Marketing Dir. LI

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,576

Underlying: Class A Common Stock · 11,576 shares

Expires 2023-12-06

F1 · derivative.exercise_price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015 and February 5, 2016.

F1 · shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015 and February 5, 2016.

F1 · price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015 and February 5, 2016.

F1 · derivative.underlying_shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015 and February 5, 2016.

F1 · balance_after: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015 and February 5, 2016.

SEC source: 0001096906-17-000275 · primary_doc.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP; Nat. Mrkt. Dir Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,155

Underlying: Class A Common Stock · 12,155 shares

Expires 2023-12-06

F3 · derivative.exercise_price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016 and February 3, 2017.

F3 · shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016 and February 3, 2017.

F3 · price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016 and February 3, 2017.

F3 · derivative.underlying_shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016 and February 3, 2017.

F3 · balance_after: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016 and February 3, 2017.

SEC source: 0001096906-17-000789 · primary_doc.xml · derivative · entry 1

Overbaugh Jason G. · CIK 0001588310 · Director · VP and Nat'l Marketing Dir. LI

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,155

Underlying: Class A Common Stock · 12,155 shares

Expires 2023-12-06

F1 · derivative.exercise_price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016 and February 3, 2017.

F1 · shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016 and February 3, 2017.

F1 · price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016 and February 3, 2017.

F1 · derivative.underlying_shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016 and February 3, 2017.

F1 · balance_after: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016 and February 3, 2017.

SEC source: 0001096906-18-000375 · primary_doc.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,763

Underlying: Class A Common Stock · 12,763 shares

Expires 2023-12-06

F3 · derivative.exercise_price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F3 · shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F3 · price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F3 · derivative.underlying_shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F3 · balance_after: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

SEC source: 0001096906-18-000701 · primary_doc.xml · derivative · entry 1

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,763

Underlying: Class A Common Stock · 12,763 shares

Expires 2023-12-06

F1 · derivative.exercise_price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F1 · shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F1 · price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F1 · derivative.underlying_shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

F1 · balance_after: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, and February 2, 2018.

SEC source: 0001096906-19-000079 · primary_doc.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,401

Underlying: Class A Common Stock · 13,401 shares

Expires 2023-12-06

F3 · derivative.exercise_price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F3 · shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F3 · price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F3 · derivative.underlying_shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F3 · balance_after: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001096906-19-000433 · primary_doc.xml · derivative · entry 1

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,401

Underlying: Class A Common Stock · 13,401 shares

Expires 2023-12-06

F1 · derivative.exercise_price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F1 · shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F1 · price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F1 · derivative.underlying_shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F1 · balance_after: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001096906-20-000010 · primary_doc.xml · derivative · entry 6

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 13,401 shares

Expires 2023-12-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F1 · shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F1 · price: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F1 · derivative.underlying_shares: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.

F1 · balance_after: This option was granted on December 6, 2013 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $4.85 per share, but adjusted pursuant to the anti-dilution provisions of the 2003 Stock Option Plan to reflect 5% stock dividends paid on February 7, 2014, February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019.